Evidence map›Paper›PMID 42511894›Full record

ReviewBiomedicines2026

RiboScreen

Genevieve Edobor, Ronald Huber, Christoph Reiter, Hanna Gercke, Niklas Kaefer, Elli Kronsteiner, Bjoern Wimmer, Marlies Wimmer, Thomas Karl, Mark Rinnerthaler and 12 more

Abstract readReview
In one paragraph

Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Genevieve EdoborDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0001-6330-7745
Ronald HuberDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0000-4375-9699
Christoph ReiterDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0009-1666-8842
Hanna GerckeDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0003-2215-6065
Niklas KaeferDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0008-0146-3046
Elli KronsteinerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0007-4532-5676
Bjoern WimmerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-9969-1256
Marlies WimmerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-2650-1332
Thomas KarlDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0001-8730-5330
Mark RinnerthalerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-1190-0584
Jan KraußDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-2040-5008
Heinrich KrobathInstitute for Theoretical Physics, Johannes Kepler University Linz, 4020 Linz, Austria.ORCID 0000-0001-6473-8109
Thomas MohrDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-1933-847X
Christopher GernerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-4964-0642
Joerg von HagenMerck KGaA , Frankfurter Straße 250, 64293 Darmstadt, Germany.ORCID 0000-0001-9810-3590
Norbert MüllerInstitute of Biochemistry, Johannes Kepler University Linz, 4020 Linz, Austria.ORCID 0000-0002-7621-3980
Helmut HintnerDepartment of Dermatology and Allergology, University Hospital Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0001-9199-0991
Bernadette LiembergerEB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-1056-362X
Ulrich KollerEB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-6285-1789
Johann W BauerDepartment of Dermatology and Allergology, University Hospital Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-6085-9170
Gazmend TemajFaculty of Pharmacy, College UBT, 10000 Prishtina, Kosovo.ORCID 0000-0003-4807-2938
Hannelore Breitenbach-KollerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-8387-6408

Funding

Land Salzburg P/147200/30
6 · The paper itself

Abstract

Across all kingdoms of life, ribosomes are indispensable molecular machines that translate genetic information into the proteome of living cells. The fundamental catalytic centers of the ribosome, constructed primarily from ribosomal RNA (rRNA), exhibit remarkable conservation between the major domains of life. The ribosome's A-site deciphers the mRNA's triplet code, while the P-site synthesizes the growing protein chain and the E-site provides exit for deacylated tRNA; a distinct tunnel facilitates nascent polypeptide export. While the conservation of ribosomal proteins is less pronounced between bacteria and eukaryotes, striking homology exists from simple eukaryotes to humans. Ribosomal proteins were traditionally viewed mainly as scaffolding agents, steering rRNA folding during ribosome biogenesis and maintaining structural stability during translation. However, since the early 2000s, advances in structural and functional ribosome analysis have ushered in a more nuanced paradigm: ribosomes are no longer considered uniform machines. Instead, an array of rRNA and ribosomal protein modifications generates a spectrum of ribosome populations capable of specialized translation. RiboScreen

Indexed as

customized protein productionnovel drug targetsprecision intervention in rare and prevalent diseaseRiboScreenTMribosomal proteins

Identifiers

PMID42511894
PMCPMC13404128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.